rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
2005-3-8
|
pubmed:abstractText |
Over-expression of the oncogene c-Myc has been implicated in the development and progression of human prostate carcinoma. However, previous assessments of c-Myc expression have not revealed its potential for predicting prostate carcinoma progression. Caveolin-1 is associated with prostate carcinoma progression and is a downstream target gene of c-Myc. The observation that caveolin-1 can suppress c-Myc-induced apoptosis suggested the potential for cooperation between c-Myc and caveolin-1 in malignant progression. In this study, the authors evaluated the prognostic potential of combined c-Myc and caveolin-1 expression in human prostate carcinoma progression.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0008-543X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
103
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1186-94
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:15712208-Adenocarcinoma,
pubmed-meshheading:15712208-Age Distribution,
pubmed-meshheading:15712208-Aged,
pubmed-meshheading:15712208-Biopsy, Needle,
pubmed-meshheading:15712208-Caveolin 1,
pubmed-meshheading:15712208-Caveolins,
pubmed-meshheading:15712208-Cohort Studies,
pubmed-meshheading:15712208-Confidence Intervals,
pubmed-meshheading:15712208-Disease Progression,
pubmed-meshheading:15712208-Humans,
pubmed-meshheading:15712208-Immunohistochemistry,
pubmed-meshheading:15712208-Male,
pubmed-meshheading:15712208-Middle Aged,
pubmed-meshheading:15712208-Predictive Value of Tests,
pubmed-meshheading:15712208-Probability,
pubmed-meshheading:15712208-Prognosis,
pubmed-meshheading:15712208-Proportional Hazards Models,
pubmed-meshheading:15712208-Prostatectomy,
pubmed-meshheading:15712208-Prostatic Neoplasms,
pubmed-meshheading:15712208-Proto-Oncogene Proteins c-myc,
pubmed-meshheading:15712208-Risk Assessment,
pubmed-meshheading:15712208-Sensitivity and Specificity,
pubmed-meshheading:15712208-Survival Analysis,
pubmed-meshheading:15712208-Tissue Culture Techniques,
pubmed-meshheading:15712208-Treatment Outcome,
pubmed-meshheading:15712208-Tumor Markers, Biological
|
pubmed:year |
2005
|
pubmed:articleTitle |
Combined c-Myc and caveolin-1 expression in human prostate carcinoma predicts prostate carcinoma progression.
|
pubmed:affiliation |
Scott Department of Urology, Baylor College of Medicine, Houston, Texas 77030, USA.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.,
Research Support, U.S. Gov't, Non-P.H.S.
|